Matrix metalloproteinases: from molecular mechanisms to physiology, pathophysiology, and pharmacology

LGN de Almeida, H Thode, Y Eslambolchi… - Pharmacological …, 2022 - Elsevier
The first matrix metalloproteinase (MMP) was discovered in 1962 from the tail of a tadpole by
its ability to degrade collagen. As their name suggests, matrix metalloproteinases are …

Metalloproteinases and their inhibitors: potential for the development of new therapeutics

M Raeeszadeh-Sarmazdeh, LD Do, BG Hritz - Cells, 2020 - mdpi.com
The metalloproteinase (MP) family of zinc-dependent proteases, including matrix
metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs), and a disintegrin …

The rebirth of matrix metalloproteinase inhibitors: moving beyond the dogma

GB Fields - Cells, 2019 - mdpi.com
The pursuit of matrix metalloproteinase (MMP) inhibitors began in earnest over three
decades ago. Initial clinical trials were disappointing, resulting in a negative view of MMPs …

[HTML][HTML] Targeting matrix metalloproteinases in cancer: bringing new life to old ideas

J Cathcart, A Pulkoski-Gross, J Cao - Genes & diseases, 2015 - Elsevier
Since the identification of matrix metalloproteinases (MMPs), a family of zinc-dependent
endopeptidases, as being a driving factor for cancer progression and patient prognosis …

[HTML][HTML] Membrane-type matrix metalloproteinases: Their functions and regulations

Y Itoh - Matrix Biology, 2015 - Elsevier
Membrane-type matrix metalloproteinases (MT-MMPs) form a subgroup of the matrix
metalloproteinase (MMP) family, and there are 6 MT-MMPs in humans. MT-MMPs are further …

The past, present and future perspectives of matrix metalloproteinase inhibitors

K Li, FR Tay, CKY Yiu - Pharmacology & therapeutics, 2020 - Elsevier
Matrix metalloproteinases (MMPs) are a large family of enzymes that degrade the
extracellular matrix (ECM). Under pathologic conditions, overexpression of MMPs or …

Current mechanistic insights into the roles of matrix metalloproteinases in tumour invasion and metastasis

GT Brown, GI Murray - The Journal of pathology, 2015 - Wiley Online Library
The purpose of this review is to highlight the recent mechanistic developments elucidating
the role of matrix metalloproteinases (MMPs) in tumour invasion and metastasis. The ability …

Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer

HK Byeon, M Ku, J Yang - Experimental & molecular medicine, 2019 - nature.com
Epidermal growth factor receptor (EGFR) overexpression is common in head and neck
squamous cell carcinoma. Targeted therapy specifically directed towards EGFR has been …

[HTML][HTML] Matrix metalloproteinases in stem cell regulation and cancer

K Kessenbrock, CY Wang, Z Werb - Matrix biology, 2015 - Elsevier
Abstract Since Gross and Lapiere firstly discovered matrix metalloproteinases (MMPs) as
important collagenolytic enzymes during amphibian tadpole morphogenesis in 1962, this …

Matrix metalloproteinases inhibitors in cancer treatment: an updated review (2013–2023)

S Almutairi, HM Kalloush, NA Manoon, SK Bardaweel - Molecules, 2023 - mdpi.com
Matrix metalloproteinases (MMPs) are identifiable members of proteolytic enzymes that can
degrade a wide range of proteins in the extracellular matrix (ECM). MMPs can be …